NYSE MKT LLC · IBO
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Impact Biomedical Inc

Impact Biomedical Inc

Pharmaceuticals
$4.48
Card
Relationship Map

Follow $IBO

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $IBO by email

Veridion Score

BETALOW CONF · 4 of 6 factors measuredMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
IBO
Impact Biomedical Inc
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

41/ 100
Veridion Score
Lower range · LOW confidence · 4 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IBO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IBO catalysts
About Impact Biomedical Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
8
Country
US

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.48
Last session
Day high
$4.48
Last session
Day low
$4.48
Last session
Previous close
$4.48
52W high
$9.84
-54.49% from high
52W low
$4.48
0% of range
Market cap
$38.3M
P/E
48.51×
EPS
$-0.0899
Beta
-0.35
Shares out
8.5M
Avg volume
22.1K
VWAP
$4.48
Last session
Price history computed in-house
1W
-17.50%
1M
-29.00%
3M
-19.68%
1Y
-42.50%
YTD
-29.70%
SMA 50 $5.81 · below
SMA 200 $6.50 · below
52W position 0%

IBO overview

Veridion Score
41
Registered · 2026-10-07
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IBO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IBO Form 4 filings
Public disclosures

Congress activity in IBO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

IBO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IBO in this window.
Lobbying spend

IBO lobbying filings, year to date.

Registered lobbying filings matched to Impact Biomedical Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IBO in this window.
Loading news for IBO
Analyst ratings
Sovereign unlock shows live analyst consensus for IBO.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.